Loading provider…
Loading provider…
Family Medicine Physician in Pensacola, FL
NPI: 1427460526Primary Practice Location
BAPTIST HOSPITAL
123 Baptist Way, Pensacola, FL
Primary Employer
Ahf
groupe-ahf.fr
HQ Phone
Get M.D. Mitchell's Phone Numberphone_androidMobile
Get M.D. Mitchell's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
SC State Medical License
2021 - 2027
FL State Medical License
2015 - 2026
MS State Medical License
2019 - 2026
GA State Medical License
2025 - 2026
AL State Medical License
2019 - 2025
LA State Medical License
2023 - 2025

American Board of Family Medicine
Family Medicine

American Academy of HIV Medicine
AAHIVS
Florida State University College Of Medicine
med.fsu.edu
Medical School
Until 2014
Tallahassee Memorial Healthcare Family Medicine
Residency • Family Medicine
2014 - 2017
Florida State University
BA • Classics
2008 - 2010
Chipola College
Chemical Science
2006 - 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 208 | 356 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 200 | 280 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 110 | 211 |
| 4 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | 39 |
| 5 | G0008Administration of influenza virus vaccine | 23 | 24 |
Lead Sponsor: ViiV Healthcare
Collaborators: Janssen, LP
Intervention / Treatment: DRUG: Cabotegravir Tablets, DRUG: Rilpivirine Tablets, DRUG: Cabotegravir Injectable Suspension (CAB LA), DRUG: Rilpivirine Injectable Suspension (RPV LA), DRUG: BIKTARVY Tablets (BIK)
Lead Sponsor: ViiV Healthcare
Collaborators: GlaxoSmithKline, PPD Development, LP
Intervention / Treatment: DRUG: DTG/3TC FDC, DRUG: CAR
Lead Sponsor: ViiV Healthcare
Intervention / Treatment: DRUG: Standard of care (SOC), BIOLOGICAL: VH3810109, DRUG: Cabotegravir, BIOLOGICAL: rHuPH20